FDA Orange Book · active-ingredient family
Mechlorethamine hydrochloride
Mechlorethamine hydrochloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:VALCHLOR · NDA 202317
2
Brand (NDA)
0
Generics (ANDA)
6
Listed patents
0
Exclusivity periods
Brand (NDA) products · gel, injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| VALCHLORRLD | HELSINN | NDA 202317 | — | Aug 23, 2013 | |
| MUSTARGENRLD | RECORDATI RARE | NDA 006695 | — | Approved Prior to Jan 1, 1982 |
Listed patents (6)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8501819 | Mar 07, 2026 | 3 mo ago | U-1427 |
| 8450375 | Mar 07, 2026 | 3 mo ago | Product |
| 8501818 | Mar 07, 2026 | 3 mo ago | Product |
| 7838564 | Mar 07, 2026 | 3 mo ago | Product |
| 9382191 | Mar 07, 2026 | 3 mo ago | Product |
| 7872050 | Jul 08, 2029 | in 3 yr 1 mo | U-1427 |
Mechlorethamine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

